Pericellular Matrix Formation Alters the Efficiency of Intracellular Uptake of Oligonucleotides in Osteosarcoma Cells

Journal of Surgical Research

Volumn 152, Issue 1, 2009, Pages 148-156

  Suzuki, Yoshitaka ^a   Nishida, Yoshihiro ^a   Naruse, Takahiro ^b   Gemba, Takefumi ^c   Ishiguro, Naoki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA KYORITSU HOSPITAL   (Japan)

^c AnGes MG Inc   (Japan)

Author keywords

extracellular matrix; NF B; oligonucleotides; osteosarcoma

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; HYALURONIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE;

ARTICLE; CELL CYCLE ARREST; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG UPTAKE; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYALURONOGLUCOSAMINIDASE; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; OLIGONUCLEOTIDES; OSTEOSARCOMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63049110174     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.02.037     Document Type: Article

References (44)

1. Harisi R., Dudas J., Timar F., et al. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture. Cell Biol Int 29 (2005) 959
2. Liotta L.A., and Kohn E.C. The microenvironment of the tumor-host interface. Nature 411 (2001) 375
3. McBride W.H., and Bard J.B. Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J Exp Med 149 (1979) 507
4. Knudson W. Hyaluronan in Malignancies. In: Laurent T.C. (Ed). The Chemistry, Biology, and Medical Applications of Hyaluronan and Its Derivatives (1998), Portland Press, London 169-179
5. Yang B., Zhang L., and Turley E.A. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 268 (1993) 8617
6. Netti P.A., Hamberg L.M., Babich J.W., et al. Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules. Proc Natl Acad Sci USA 96 (1999) 3137
7. Gribbon P.M., Maroudas A., Parker K.H., et al. Water and solute transport in the extracellular matrix: Physical principles and macromolecular determinants. In: Reed R.K., and Rubin K. (Eds). Connective Tissue Biology: Integration and Reductionism (1998), Portland Press, London 95-124
8. Levick J.R. Flow through interstitium and other fibrous matrices. Q J Exp Psychol 72 (1987) 409
9. Comper W.D., and Laurent T.C. Physiological function of connective tissue polysaccharides. Physical Rev 58 (1978) 255
10. Abdel-Latif M.M., O'Riordan J., Windle H.J., et al. NF-κB activation in esophageal adenocarcinoma: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 239 (2004) 491
11. Nair A., Venkatraman M., Maliekal T.T., et al. NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22 (2003) 50
12. Oya M., Takayanagi A., Horiguchi A., et al. Increased nuclear factor-κ B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24 (2003) 377
13. Javelaud D., Poupon M.F., Wietzerbin J., et al. Inhibition of constitutive NF-κB activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer 98 (2002) 193
14. Uetsuka H., Haisa M., Kimura M., et al. Inhibition of inducible NF-κB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line. Exp Cell Res 289 (2003) 27
15. Morishita R., Sugimoto T., Aoki M., et al. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3 (1997) 894
16. Morishita R., Aoki M., and Kaneda Y. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease. Ann NY Acad Sci 947 (2001) 294
17. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 787
18. Chen F.E., Huang D.B., Chen Y.Q., et al. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391 (1998) 410
19. Harimaya K., Tanaka K., Matsumoto Y., et al. Antioxidants inhibit TNFα-induced motility and invasion of human osteosarcoma cells: Possible involvement of NFκB activation. Clin Exp Metast 18 (2000) 121
20. Dorfman H.D., and Czerniak B. Osteosarcoma. In: Dorfman H.D., and Czerniak B. (Eds). Bone Tumors (1998), Mosby, St. Louis 128-252
21. Unni K.K. Osteosarcoma. In: Unni K.K. (Ed). Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases (1996), Lippincott-Raven, Philadelphia 143-183
22. Nishida Y., Knudson W., Knudson C.B., et al. Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. Exp Cell Res 307 (2005) 194
23. Hosono K., Nishida Y., Knudson W., et al. Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 171 (2007) 274
24. Harisi R., Dudas J., Timar F., et al. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix. Anticancer Res 25 (2005) 805
25. Meredith Jr. J.E., Fazeli B., and Schwartz M.A. The extracellular matrix as a cell survival factor. Mol Biol Cell 4 (1993) 953
26. Rintoul R.C., and Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci (Lond) 102 (2002) 417
27. Pogany G., Timar F., Olah J., et al. Role of the basement membrane in tumor cell dormancy and cytotoxic resistance. Oncology 60 (2001) 274
28. Knudson C.B. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol 120 (1993) 825
29. Nishida Y., Knudson W., and Knudson C.B. Extracellular matrix recovery by human articular chondrocytes after treatment with hyaluronan hexasaccharides or Streptomyces hyaluronidase. Mod Rheumatol 13 (2003) 62
30. Netti P.A., Berk D.A., Swartz M.A., et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60 (2000) 2497
31. Davies C., Berk D.A., Pluen A., et al. Comparison of IgG diffusion and extracellular matrix composition in rhabdomyosarcomas grown in mice versus in vitro as spheroids reveals the role of host stromal cells. Br J Cancer 86 (2002) 1639
32. Qiu X.L., Brown L.V., Parameswaran S., et al. Effect of hyaluronidase on albumin diffusion in lung interstitium. Lung 177 (1999) 273
33. Loke S.L., Stein C.A., Zhang X.H., et al. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86 (1989) 3474
34. Yakubov L.A., Deeva E.A., Zarytova V.F., et al. Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors?. Proc Natl Acad Sci USA 86 (1989) 6454
35. Akhtar S., and Juliano R.L. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends in Cell Biol 2 (1992) 139-144
36. Beltinge C., Saragovi H.U., Smith R.M., et al. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 95 (1995) 1814
37. Ichikawa H., Takada Y., Murakami A., et al. Identification of a novel blocker of I κB α kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-κB regulated gene products. J Immunol 174 (2005) 7383
38. Takada Y., Andreeff M., and Aggarwal B.B. Indole-3-carbinol suppresses NF-κB and IκB α kinase activation, causing inhibition of expression of NF-κ regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106 (2005) 641
39. Roszkowski P., Wronkowski Z., Szamborski J., et al. Evaluation of selected prognostic factors in ovarian cancer. Eur J Gynaecol Oncol 14 (1993) 140
40. Raymond A.K., Ayala A.G., and Knuutila S. Conventional Osteosarcoma. In: Kleihues P., Sobin L., Fletcher C., et al. (Eds). WHO Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone (2002), IARC Press, Lyon, France 264-270
41. Swiwat S., Ricciarlli C., Tammi R., et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 10 (2004) 2491
42. Harisi R., Dudas J., Nagy-Olah J., et al. Extracellular matrix induces doxorubicin-resistance in human osteosarcoma cells by suppression of p53 function. Cancer Biol Ther 6 (2007) 1240
43. Smith K.J., Skelton H.G., Turiansky G., et al. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. J Am Acad Dermatol 36 (1997) 239
44. Spruβ T., Bernhardt H., Schonenberger H., et al. Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol 121 (1995) 193